Tag: Drug induced neutropenia

Neutropenia is a common hematologic finding in clinical practice, characterized by an abnormally low number of neutrophils in the bloodstream. A deficiency in these key infection-fighting cells can lead to serious, life-threatening infections, making prompt and accurate diagnosis critical for patient safety. Understanding **why your patient has neutropenia** requires a methodical approach, exploring the diverse array of underlying causes that can disrupt neutrophil production or lead to their accelerated destruction.

According to the American Cancer Society, neutropenia is a common and often expected side effect of cancer treatments like chemotherapy. Identifying what is the most common cause of neutropenia, however, requires looking at a broader range of factors, as it varies depending on the patient's overall health and circumstances.